---
title: "SFPM: The application for the registration and listing license of Clobetasol Propionate Ointment has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263250865.md"
description: "SFPM announced that its wholly-owned subsidiary Harbin SFPM received the \"Acceptance Notice\" from the National Medical Products Administration regarding the application for the registration and marketing authorization of Clobetasol Propionate Ointment. Clobetasol Propionate Ointment is suitable for topical treatment of mild to moderate atopic dermatitis in patients aged 3 months and older. The company will actively promote the marketing authorization process for this product and continuously monitor the approval status, fulfilling its information disclosure obligations in a timely manner"
datetime: "2025-10-29T09:24:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263250865.md)
  - [en](https://longbridge.com/en/news/263250865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263250865.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263250865.md) | [繁體中文](https://longbridge.com/zh-HK/news/263250865.md)


# SFPM: The application for the registration and listing license of Clobetasol Propionate Ointment has been accepted

SFPM announced that its wholly-owned subsidiary Harbin SFPM received the "Acceptance Notice" from the National Medical Products Administration regarding the application for the registration and marketing license of Clobetasol Propionate Ointment. Clobetasol Propionate Ointment is suitable for topical treatment of mild to moderate atopic dermatitis in patients aged 3 months and older. The company will actively promote the marketing license work for this product and continuously monitor the approval status, fulfilling its information disclosure obligations in a timely manner

### Related Stocks

- [SFPM (002737.CN)](https://longbridge.com/en/quote/002737.CN.md)

## Related News & Research

- [08:24 ETZentiva vydává Zprávu o udržitelnosti za rok 2025, čímž posiluje svůj závazek vůči lidem, partnerům a planetě.](https://longbridge.com/en/news/279431011.md)
- [Trump to hold news conference Monday prior to Kennedy Center board meeting](https://longbridge.com/en/news/279284985.md)
- [Together Ever Introduces Revionyx™ to Support Healthy Aging in Premium Pet Nutrition](https://longbridge.com/en/news/279375378.md)
- [Glenmark Pharmaceuticals to Launch Potassium Phosphates Injection in March](https://longbridge.com/en/news/279206533.md)
- [Bambu Lab said to have resolved Labubu IP dispute with Pop Mart](https://longbridge.com/en/news/279197529.md)